bacterial protein enhances release efficacy liposomal cancer drugs 
clostridium novyi-nt anaerobic bacterium can infect hypoxic regions within experimental tumors c novyi-nt lyses red blood cells hypothesized membrane-disrupting properties exploited enhance release liposome-encapsulated drugs within tumors show treatment mice bearing large established tumors c novyi-nt plus single dose liposomal doxorubicin often led eradication tumors bacterial factor responsible enhanced drug release identified previously unrecognized protein termed liposomase protein potentially incorporated diverse experimental approaches specific delivery chemotherapeutic agents tumors 
